Related references
Note: Only part of the references are listed.Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience
Mahalakshmi Nagarajan et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Is Botulinum Toxin Useful in Systemic Sclerosis Related Peripheral Vasculopathy? A Literature Review
Miguel Gomes Guerra et al.
REUMATOLOGIA CLINICA (2021)
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon
Daniel Ennis et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)
Botulinum toxin type A in the treatment of Raynaud's phenomenon
S. Meelad Habib et al.
DERMATOLOGIC THERAPY (2020)
Microvascular hand surgery for digital ischemia in scleroderma
Ellen S. Satteson et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study
Susana Medina et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2018)
The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ricardo J. Bello et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study
Sei-ichiro Motegi et al.
JOURNAL OF DERMATOLOGY (2016)
The Role of Botulinum Toxin A in the Treatment of Raynaud Phenomenon
Francesco Segreto et al.
ANNALS OF PLASTIC SURGERY (2016)
Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
Pawel Zebryk et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
Digital Sympathectomy in Patients With Scleroderma An Overview of the Practice and Referral Patterns and Perceptions of Rheumatologists
Grace Chiou et al.
ANNALS OF PLASTIC SURGERY (2015)
Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma
Laura Cappelli et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma
L. Uppal et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2014)
Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis
J. Serri et al.
ANNALES DE CHIRURGIE PLASTIQUE ESTHETIQUE (2013)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Measures of Adult Pain Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)
Gillian A. Hawker et al.
ARTHRITIS CARE & RESEARCH (2011)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Botulinum Toxin Type A in the Treatment of Raynaud's Phenomenon
Michael W. Neumeister
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2010)
Cellular and molecular aspects of vascular dysfunction in systemic sclerosis
Maria Trojanowska
NATURE REVIEWS RHEUMATOLOGY (2010)
Botulinum Toxin Type A: A Treatment Option for Digital Ischemia in Patients With Raynaud's Phenomenon
Alero Fregene et al.
JOURNAL OF HAND SURGERY-AMERICAN VOLUME (2009)
Botox Therapy for Ischemic Digits
Michael W. Neumeister et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2009)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Management of vasospastic disorders with botulinum toxin A
Allen L. Van Beek et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2007)
Development of the QuickDASH: Comparison of three item-reduction approaches
DE Beaton et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2005)
Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study
T Sycha et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons
JL Morris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Share Paper
